Posted by Michael Wonder on 23 Feb 2017
Uncertainty on R&D tax incentive causing real harm
23 February 2017 - Constant reviews and recent changes to the Research and Development (R&D) Tax Incentive are jeopardising Australian innovation and prompting Australian biotechnology firms to reconsider their R&D investment strategy, says the McKell Institute.
In a recent report, Committing to the Innovation Nation: Why the R&D Tax Incentive is so important for Australia, the McKell Institute examined how R&D policy instability affects the Australian biotechnology industry.
The McKell Institute called for the Government to leave the R&D Tax Incentive in its current form, emphasising its essential role in advancing Australia as an innovation nation.
